Recently, αβ-T cells were shown to aberrantly express high levels of FcγRIIIA in severely diseased COVID-19 patients where they exert polyclonal TCR-independent highly cytotoxic T cell responses [12]. The gene discussed is FCGR3A; the disease is COVID-19.